<unk>  is a integrase inhibitor that is FDA approved for the {{{indicationType}}} of HIV-1 infection in patients 4 weeks of age and older.   Common adverse reactions include insomnia, headache, dizziness, nausea and fatigue.
Raltegravir
Saquinavir
Fosamprenavir
Entecavir
Telbivudine
Abacavir
Lamivudine
Tipranavir